-
BioGeneration Ventures announces first close of its third fund
July 5, 2016BioGeneration Ventures announces first close of its third fund Providing fresh capital to innovative Dutch and other European Life...
0 -
Forbion closes third life sciences fund, FCF III
April 12, 2016Forbion closes third life sciences fund, FCF III, raising over $200m Investment focus on European, US & Canadian private...
-
Amgen acquires Forbion portfolio company Dezima Pharma
September 17, 2015Amgen acquires Forbion portfolio company Dezima Pharma Upfront payment of USD 300m plus up to USD 1.25bn in development...
-
Forbion announces the closing of FCF II Co-Invest Fund I at EUR 75M
September 10, 2015Forbion announces the closing of FCF II Co-invest Fund I at EUR 75M Naarden, The Netherlands, 10 September...
-
Forbion Announcement Promedior
September 1, 201531 August 2015 Forbion Announces – Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its...
-
Forbion announces that Pfizer acquires interest in its portfolio Company AM-Pharma
May 12, 2015Pfizer acquires minority interest in AM-Pharma; Secures option to acquire company. Option may be exercised based on Phase II...
-
Forbion Capital Partner Invests EUR 2.4 Million in 2nd Closing of Series A Financing Round for Rigontec GmbH
March 24, 2015For immediate release 24 March 2015  Forbion Capital Partners Invests EUR 2.4 Million in 2nd Closing of Series...
-
Forbion Announces Sale of Portfolio Company PneumRx
December 5, 2014Forbion Announces Sale of Portfolio Company PneumRx to BTG for up to USD 475M (EUR 385M) Naarden, The Netherlands, December...
-
Forbion Capital Partners Announces First Close of FCF III
October 3, 2014For immediate release 3 October 2014 Forbion Capital Partners Announces First Close of FCF III Naarden, The...
-
Forbion Portfolio Company News: Dezima
September 12, 2014Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia Combines outstanding efficacy...